FDG–PET–CT and whole-body MRI for triage in patients planned for radioembolisation therapy
Creators
- 1. Department of Clinical Radiology, University Hospitals Munich – Grosshadern, LMU, Marchioninistr. 15, 81377 München (Germany)
- 2. Department of Nuclear Medicine, University Hospitals Munich – Grosshadern, LMU (Germany)
Description
Purpose: The purpose was to evaluate the potential of FDG–PET–CT and whole-body MRI (WB-MRI) as diagnostic triage methods for patients planned for radioembolisation of metastatic liver disease. Materials and methods: 135 patients with multifocal liver metastases were evaluated for potential palliative therapy with radioembolisation using 90-Yttrium microspheres. All patients were examined consecutively with FDG–PET–CT and WB-MRI for exclusion of relevant extra-hepatic tumor manifestations. All patients underwent 99mTc-albumine angiography followed by scintigraphy to exclude significant hepato-pulmonary shunting. Results: Out of the 135 patients included into the pre-therapeutic diagnostic algorithm, 56% were eligible and received radioembolisation, while 44% could not be treated. In 91% the exclusion criteria was diagnosis of significant extra-hepatic metastatic disease. In 85% exclusion diagnosis was made concordantly by both FDG–PET–CT and WB-MRI, in 9% diagnosis was provided by PET–CT, in 6% by WB-MRI alone. Patient-based sensitivity for detection of extra-hepatic disease was 94% for PET–CT and 91% for WB-MRI. False-positive diagnosis of extrahepatic disease leading to exclusion for radioembolisation therapy was made in 2% of patients, in one patient by PET–CT and in one patient by WB-MRI alone. Overall, specificity for inclusion of radioembolisation therapy by combining both modalities was 99%. In 9% of patients angiographic diagnosis made radioembolisation impossible, in 7% solely the angiographic findings were decisive. Conclusion: Both FDG–PET–CT and WB-MRI are efficient diagnostic triage methods for patients planned for radioembolisation of liver metastases. Overall, FDG–PET–CT shows a trend to higher diagnostic accuracy compared to WB-MRI and may be used as imaging method of choice as a standalone examination. In combination, both modalities exhibited high sensitivity for the diagnosis of extra-hepatic tumor manifestations and result in high specificity.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ejrad.2011.02.018Additional details
Identifiers
- DOI
- 10.1016/j.ejrad.2011.02.018;
- PII
- S0720-048X(11)00203-8;
Publishing Information
- Journal Title
- European Journal of Radiology
- Journal Volume
- 81
- Journal Issue
- 3
- Journal Page Range
- p. e269-e276
- ISSN
- 0720-048X
- CODEN
- EJRADR
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 43078511
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ACCURACY; ALGORITHMS; BIOMEDICAL RADIOGRAPHY; BLOOD VESSELS; DIAGNOSIS; LIVER; METASTASES; MICROSPHERES; NEOPLASMS; NMR IMAGING; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; SCINTISCANNING; SENSITIVITY; SPECIFICITY; TECHNETIUM 99; THERAPY; YTTRIUM 90
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CARDIOVASCULAR SYSTEM; COMPUTERIZED TOMOGRAPHY; COUNTING TECHNIQUES; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; EMISSION COMPUTED TOMOGRAPHY; GLANDS; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MATHEMATICAL LOGIC; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOISOTOPE SCANNING; RADIOISOTOPES; RADIOLOGY; TECHNETIUM ISOTOPES; TOMOGRAPHY; YEARS LIVING RADIOISOTOPES; YTTRIUM ISOTOPES
Optional Information
- Copyright
- Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.